PATENT CLAIM ANALYSIS

Application Number: 15880032
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "04400A"]

Abstract:
A method is provided for decreasing at least one of the proliferation and the migration of a cancer cell comprising contacting a cancer cell with an effective amount of a pharmaceutically acceptable composition comprising a microRNA (miRNA) having a nucleotide sequence having at least 80% sequence similarity to the nucleotide sequence of miR-3189-3p derived from the miR-3189 mitron of the Growth Differentiation Factor 15 (GDF15) gene. The methods and compositions are advantageous for inhibiting proliferation and migration of, but not limited to, glioblastoma cells, melanoma cells, and breast cancer cells.

Claim (Index 14):
The method of  claim 11 , wherein the glioblastoma multiforme is located in the brain or the spinal cord of the subject.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 86.0
- Lexical Diversity: 1.60317
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775667', '14615168', '15744086', '13567852', '13581032']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.782329652227763
- 35 USC 102 Novelty (BERT): 0.5197503253031516
- Combined Prediction Score: 0.756071719535302
- Mean Citation Score: 275.689548
- Max Citation Score: 305.58878
- Similarity Product: 209.9663511231637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test